Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
2002 4
2003 8
2004 2
2005 3
2006 7
2007 4
2008 5
2009 9
2010 9
2011 12
2012 12
2013 25
2014 23
2015 20
2016 15
2017 10
2018 17
2019 12
2020 12
2021 7
2022 6
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

201 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean chung hyun h (161 results)?
Evaluation of novel pyrazol-4-yl pyridine derivatives possessing arylsulfonamide tethers as c-Jun N-terminal kinase (JNK) inhibitors in leukemia cells.
Mersal KI, Abdel-Maksoud MS, Ali EMH, Ammar UM, Zaraei SO, Haque MM, Das T, Hassan NF, Kim EE, Lee JS, Park H, Lee KH, El-Gamal MI, Kim HK, Ibrahim TM, Oh CH. Mersal KI, et al. Among authors: oh ch. Eur J Med Chem. 2023 Dec 5;261:115779. doi: 10.1016/j.ejmech.2023.115779. Epub 2023 Sep 15. Eur J Med Chem. 2023. PMID: 37776574
Design and synthesis of new adamantyl derivatives as promising antiproliferative agents.
Shahin AI, Zaraei SO, AlKubaisi BO, Ullah S, Anbar HS, El-Gamal R, Menon V, Abdel-Maksoud MS, Oh CH, El-Awady R, Gelsleichter NE, Pelletier J, Sévigny J, Iqbal J, Al-Tel TH, El-Gamal MI. Shahin AI, et al. Among authors: oh ch. Eur J Med Chem. 2023 Jan 15;246:114958. doi: 10.1016/j.ejmech.2022.114958. Epub 2022 Nov 26. Eur J Med Chem. 2023. PMID: 36470105
Structural optimization of 4-(imidazol-5-yl)pyridine derivatives affords broad-spectrum anticancer agents with selective B-RAFV600E/p38α kinase inhibitory activity: Synthesis, in vitro assays and in silico study.
Ali EMH, Mersal KI, Ammar UM, Zaraei SO, Abdel-Maksoud MS, El-Gamal MI, Haque MM, Das T, Kim EE, Lee JS, Lee KH, Kim HK, Oh CH. Ali EMH, et al. Among authors: oh ch. Eur J Pharm Sci. 2022 Apr 1;171:106115. doi: 10.1016/j.ejps.2022.106115. Epub 2022 Jan 4. Eur J Pharm Sci. 2022. PMID: 34995782 Free article.
201 results